Location: Home
  • search
  • go
  • Relate News
  • 12/29/2022NMPA Participates in the CIMDR - GHWP Session & International Drug Reg...
  • 12/29/2022NMPA Issues the Provisions on Facilitating Main Responsibility of MAHs...
  • 12/29/2022NMPA Announces Package Insert Revision of Prednisolone Inj, Pethidine ...
  • 12/29/2022CDE Publicizes Its Proposed List of External Clinical Experts for Pedi...
  • 12/29/2022Shionogi Inks Deal with Chia Tai Tianqing Pharma to Market COVID Pil...
  • 12/28/2022InnoCare Receives Approval of Tafasitamab in Combo with Lenalidomide f...
  • 12/28/2022NMPA Issues the List of Reference Formulations for GQCE Studies (62nd ...
  • 12/28/2022Everest Medicines Begins Operations at mRNA Vaccine Production Site in...
  • 12/27/2022Antengene and Merck Enter into a Global Clinical Collaboration with M...
  • 12/27/2022Mainland Chinese May Now Get BioNTech COVID-19 Vaccines in Hong Kong...
  • 12/27/2022Chinese Flock to Smuggled India-made Meds amid COVID Scare
  • 12/27/2022China Scraps Quarantine Rule for International Travel and Distributes ...
  • 12/26/2022Data Snapshot: Top Ten Chinese Pharma Outlicensing Deals by Value 2021...
  • 12/26/2022NHSA Announces Comprehensive Inspection of Irregular BMI Coverage Rest...
  • 12/26/2022Hikma and Junshi Sign Exclusive Licensing Pact for Anticancer Toripali...
  • 12/26/2022Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 12/26/2022Two Large Out-licensing Deals Edge November Deal Values to Over $2.9B ...
  • 12/23/2022Beijing's Covid Wave May Have Peaked But China's Tsunami of Cases Is M...
  • 12/23/2022Eisai Initiates BLA Filing for Alzheimer's Drug Lecanemab in China
  • 12/23/2022Drug R&D and Product Registration News Digest December 2022 (3)
  • 12/22/2022Merck and Kelun Ink Exclusive License Pact for Seven Investigational ...
  • 12/22/2022NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
  • 12/22/2022NMPA and Chinese Customs Issues the Announcement for Regulation of Imp...
  • 12/22/2022CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
  • 12/22/2022CDE Seeks Public Comments on the Technical Guidelines for Immunogenic ...
  • 12/22/2022CDE Seeks Public Comments on the Technical Guidelines for Clinical Tri...
  • 12/21/2022NMPA Solicits Comments on the Guidelines for the Study of Disease Natu...
  • 12/21/2022Shanghai Looks to Turn Pharmacies into Healthcare Service Providers
  • 12/21/2022XtalPi and EDDC Partner in AI-empowered Drug Discovery Program for NSC...
  • 12/21/2022BioNTech Sends First Batch of Vaccine to China for German Residents Th...
  • Page:61/719 Total number of articles:21546: [First][<<] [59] [60] [61] [62] [63] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group